Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
27.60
+0.26 (0.95%)
Feb 13, 2026, 4:08 PM HKT
Market Cap12.61B
Revenue (ttm)61.85M
Net Income-243.14M
EPS-0.58
Shares Out456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume163,200
Average Volume1,717,171
Open27.02
Previous Close27.34
Day's Range27.02 - 27.84
52-Week Range25.50 - 74.00
Betan/a
RSI39.23
Earnings DateNov 6, 2025

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 105
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements